Intas Pharmaceuticals Patents – Insights & Stats (Updated 2024)

Intas Pharmaceuticals has a total of 571 patents globally, out of which 146 have been granted. Of these 571 patents, more than 77% patents are active. India is where Intas Pharmaceuticals has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, India seems to be the main focused R&D centre and also is the origin country of Intas Pharmaceuticals.

Intas Pharmaceuticals was founded in 1977. Intas Pharmaceuticals is a global pharmaceutical company offering biopharmaceutical products and services. They specialize in oncology products for solid tumors, blood cancers, and supportive therapies, as well as treatments for critical disorders. Their success and growth over three decades are due to strategic moves in manufacturing, R&D, biotechnology, and global operations.

Do read about some of the most popular patents of Intas Pharmaceuticals which have been covered by us in this article and also you can find Intas Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Intas Pharmaceuticals patent portfolio.

How many patents does Intas Pharmaceuticals have?

Intas Pharmaceuticals has a total of 571 patents globally. These patents belong to 174 unique patent families. Out of 571 patents, 250 patents are active.

How Many Patents did Intas Pharmaceuticals File Every Year?

Intas Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIntas Pharmaceuticals Applications FiledIntas Pharmaceuticals Patents Granted
20246
2023620
20224515
20212215
20208921
20193418
2018419
2017465
20162610
2015442
2014612

How many Intas Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Intas Pharmaceuticals Patent Portfolio

How Many Patents did Intas Pharmaceuticals File in Different Countries?

Intas Pharmaceuticals Worldwide Patent Filing

Countries in which Intas Pharmaceuticals Filed Patents

CountryPatent
India155
United States of America52
Europe (EPO)51
Canada33
Australia17
Mexico16
Germany16
Brazil15
Austria15
Spain12
South Africa12
New Zealand10
Japan9
China6
Russian Federation5
Chile5
Portugal4
Poland4
Italy4
Singapore4
Denmark3
Malaysia3
Israel3
Philippines3
United Kingdom3
Indonesia3
Malta2
Hong Kong (S.A.R.)2
Slovakia2
Viet Nam2
Colombia2
Serbia2
Korea (South)2
Norway2
Argentina2
Uruguay1
Croatia1
Turkey1
Hungary1
Slovenia1
Taiwan1
Cyprus1
Thailand1
Lithuania1

Where are Research Centers of Intas Pharmaceuticals Patents Located?

R&D Centres of Intas Pharmaceuticals

10 Best Intas Pharmaceuticals Patents

WO2011141926A2 is the most popular patent in the Intas Pharmaceuticals portfolio. It has received 155 citations so far from companies like Coherus Biosciences, LG Life Sciences, Amgen.

Below is the list of 10 most cited patents of Intas Pharmaceuticals:

Publication NumberCitation Count
WO2011141926A2155
WO2011004395A142
WO2015151115A132
US6710195B217
WO2015095651A113
WO2014102814A112
WO2014118807A111
US20090275647A19
WO2015198257A19
US20110177137A18

What are Intas Pharmaceuticals key innovation segments?

What Technologies are Covered by Intas Pharmaceuticals?

The chart below distributes patents filed by Intas Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Intas Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Intas Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Intas Pharmaceuticals?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.